Zantac’s manufacturers were on a roll ... “[W]e’re out to dominate the entire product category.” (emphasis in original).” Another verdict-inflamer is spoilation, i.e., destroying relevant evidence ...

As is customary with similar transactions, Zantac 2 and Gold Bond are excluded from the scope of the contemplated transaction. The original 2024 business EPS guidance issued on February 1, 2024, and ...

Global stock markets hold their breath as a neck-and-neck US election race leaves the future uncertain. I'm not taking any ...

As is customary with similar transactions, Zantac 2 and Gold Bond are excluded from the scope of the contemplated transaction. The original 2024 business EPS guidance issued on February 1, 2024, and ...

GSK has also reached an agreement to pay $70 million to resolve the Zantac Qui Tam suit previously filed by Valisure. The arrangement is awaiting final approval from the Department of Justice.

Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.

GSK and other drugmakers have lost no time in filing an appeal to a Delaware court’s decision to allow more than 70,000 Zantac-related lawsuits to go ahead. Just over a week ago, Judge Vivian ...